Audiological Science, a London-based developer of hearing-related medical technology, has received a £12.4m investment from YFM Equity Partners.
The investment will support the company’s growth plans, with aims to expand into new NHS regions as public health services in Britain face pressure to meet community demands.
Audiological Sciece was founded in 2014 and now works with nine Integrated Care Boards – NHS organisations that plan health services for local populations – across England.
“YFM are helping us to lay the foundations for the next phase of our growth journey. Their financial support is complemented by leading strategic insight, which will ensure we’re perfectly positioned to achieve our scale-up ambitions,” said Deep Patel, managing director at Audiological Science.
As the company looks to expand, Patel will be joined by newly appointed non-executive chair Jon Lowe – formerly the CEO of Connect Health – and CFO Phil Semke.
“Deep and his team have really impressed us with their strong insight into the audiology market, and how they have developed a scalable model with community care at its heart,” added Adam Hart, investment director at YFM.
“The business has been growing rapidly, and we’re delighted to be supporting them on the next stage of their journey alongside a high-calibre, sector experienced, non-executive chair.”
Audiological Science provides a range of products under the umbrella of ear health, including hearing tests and hearing aids.
According to Companies House documents, the firm has around 30 staff and holds assets worth £4.2m.
A 2024 study from the universities of Manchester and Nottingham found that more than a quarter of the UK’s population are estimated to have some form of hearing loss.
Though it is most associated with older patients, the audio health startup Eargym found in a study of 1,000 people aged 16 to 35 that a quarter showed early signs of hearing loss.
Read more: Early Impact: How Eargym is helping young and old protect their hearing
Register for Free
Get daily updates and enjoy an ad-reduced experience.
Already have an account? Log in
